Dr. Vaitkevicius is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1672 Washington St
Ph 2
Boston, MA 02118Phone+1 313-333-5508Fax+1 617-732-5539
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2008 - 2011
Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 2007 - 2008
Wayne State University School of MedicineClass of 2007
Certifications & Licensure
NH State Medical License 2013 - Present
MI State Medical License 2007 - 2027
IL State Medical License 2021 - 2026
CA State Medical License 2021 - 2025
MA State Medical License 2010 - 2025
NJ State Medical License 2021 - 2025
NY State Medical License 2022 - 2025- American Board of Psychiatry and Neurology Neurology
- United Counsil of Neurologic SubspecialtiesNeurocritical Care
- Join now to see all
Clinical Trials
- Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus Start of enrollment: 2014 Mar 21
Publications & Presentations
PubMed
- 94 citationsNeuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema.Matthew Torre, Isaac H. Solomon, Claire L Sutherland, Sarah Nikiforow, Daniel J. DeAngelo
Journal of Neuropathology and Experimental Neurology. 2018-10-01 - 64 citationsClinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy.Daniel B. Rubin, Ali Al Jarrah, Karen Li, Sarah LaRose, Andrew D. Monk
JAMA Neurology. 2020-12-01 - 24 citationsIntravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial.Henrikas Vaitkevicius, R Eugene Ramsay, Christa B Swisher, Aatif M Husain, Alex Aimetti
Epilepsia. 2022-09-01
Press Mentions
Marinus Pharmaceuticals Announces Formation of Scientific Advisory BoardApril 30th, 2020
Marinus Phase 2 Clinical Data on Ganaxolone in RSE Presented at Neurocritical Care Society MeetingOctober 17th, 2019
Neurological Effects of CAR-T TherapyMay 23rd, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
